Risk for stroke and myocardial infarction with abiraterone versus enzalutamide in metastatic prostate cancer patients

A. A. Kulkarni, N. Rubin, A. Tholkes, S. Shah, C. J. Ryan, P. L. Lutsey, A. Prizment, A. Rao

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Risk for stroke and myocardial infarction with abiraterone versus enzalutamide in metastatic prostate cancer patients'. Together they form a unique fingerprint.

Medicine & Life Sciences